Quisinostat (JNJ-26481585) is a novel second-generation HDACi inhibitor with highest potency for HDAC1 with IC50 of 0.11 nM, modest potent to HDACs 2, 4, 10, and 11; greater than 30-fold selectivity against HDACs 3, 5, 8, and 9 and lowest potency to HDACs 6 and 7. , in NSCLC cells. In vitro, quisinostat has shown anti-proliferative activity against NSCLC cell lines. quisinostat extremely changed protein acetylation patterns of A549 cells and inhibited epithelial-mesenchymal transition (EMT) process.
MoreHerbimycin A是Src 家族激酶抑制剂。也是Hsp90 抑制剂。
MoreGedunin是Hsp90 抑制剂, 展现抗肿瘤抗疟活性。。
MoreEC 144是高亲和性,活性的选择性 Hsp90 抑制剂。
MoreCCT 018159是Hsp90 抑制剂。
More